43 results on '"Raška M"'
Search Results
2. Antibody Response of Dogs After Immunisation with Chimeric Vaccine Against Borreliosis
- Author
-
Nepereny, J., Vrzal, V., Raska, M., Weigl, E., Krupka, M., Turanek, J., and Masek, J.
- Published
- 2015
- Full Text
- View/download PDF
3. Candidiasis — Do we need to fight or to tolerate theCandida fungus?
- Author
-
Raška, M., Běláková, J., Křupka, M., and Weigl, E.
- Published
- 2007
- Full Text
- View/download PDF
4. Heat shock proteins in immune reactions
- Author
-
Weigl, E., Kopeček, P., Raška, M., and Hradilová, Š.
- Published
- 1999
- Full Text
- View/download PDF
5. Development of the primer set for the detection of thehsp60 gene inTrichophyton mentagrophytes cDNA
- Author
-
Kopeček, P., Raška, M., and Weigl, E.
- Published
- 1999
- Full Text
- View/download PDF
6. Detection of antigens in mycelial and in arthroconidial phases ofTrichophyton mentagrophytes
- Author
-
Kopeček, P., Weigl, E., and Raška, M.
- Published
- 1998
- Full Text
- View/download PDF
7. Patients With IgA Nephropathy Have Altered Levels of Immunomodulatory C19 Steroids. Glucocorticoid Therapy With Addition of Adrenal Androgens May Be the Choice
- Author
-
ŠTERZL, I., primary, HILL, M., additional, STÁRKA, L., additional, VELÍKOVÁ, M., additional, KANČEVA, R., additional, JEMELKOVÁ, J., additional, CZERNEKOVÁ, L., additional, KOSZTYU, P., additional, ZADRAŽIL, J., additional, MATOUŠOVIC, K., additional, VONDRÁK, K., additional, and RAŠKA, M., additional
- Published
- 2017
- Full Text
- View/download PDF
8. Bone remodeling, particle disease and individual susceptibility to periprosthetic osteolysis
- Author
-
Gallo, J, primary, Raška, M, additional, Mrázek, F, additional, and Petrek, M, additional
- Published
- 2008
- Full Text
- View/download PDF
9. Candidiasis — Do we need to fight or to tolerate the Candida fungus?
- Author
-
Raška, M., Běláková, J., Křupka, M., and Weigl, E.
- Abstract
Candidiases, infections caused by germination forms of the Candida fungus, represent a heterogeneous group of diseases from systemic infection, through mucocutaneous form, to vulvovaginal form. Although caused by one organism, each form is controlled by distinct host immune mechanisms. Phagocytosis by polymorphonuclears and macrophages is generally accepted as the host immune mechanism for Candida elimination. Phagocytes require proinflammatory cytokine stimulation which could be harmful and must be regulated during the course of infection by the activity of CD8
+ and CD4+ T cells. In the vaginal tissue the phagocytes are inefficient and inflammation is generally an unwanted reaction because it could damage mucosal tissue and break the tolerance to common vagina antigens including the otherwise saprophyting Candida yeast. Recurrent form of vulvovaginal candidiasis is probably associated with breaking of such tolerance. Beside the phagocytosis, specific antibodies, complement, and mucosal epithelial cell comprise Candida eliminating immune mechanisms. They are regulated by CD4+ and CD8+ T cells which produce cytokines IL-12, IFN-γ, IL-10, TGF-β, etc. as the response to signals from dendritic cells specialized to sense actual Candida morphotypes. During the course of Candida infection proinflammatory signals (if initially necessary) are replaced successively by antiinflammatory signals. This balance is absolutely distinct during each candidiasis form and it is crucial to describe and understand the basic principles before designing new therapeutic and/or preventive approaches. [ABSTRACT FROM AUTHOR]- Published
- 2007
- Full Text
- View/download PDF
10. Development of the primer set for the detection of the hsp60 gene in Trichophyton mentagrophytes cDNA.
- Author
-
Kopeček, P., Raška, M., and Weigl, E.
- Abstract
Three sequences of hsp60 from Saccharomyces cerevisiae, Schizosaccharomyces pombe and Histoplasma capsulatum were compared. Local multiple alignment of these sequences allowed the selection of two oligonucleotides suitable as primers for the polymerase chain reaction. This primer set was used for the amplification of a part of the hsp60 gene from cDNA of Trichophyton mentagrophytes and S. cerevisiae. Similar fragments detected in both PCR’s imply the possible future use of the developed primer set for the detection of the hsp60 gene in other fungal species. [ABSTRACT FROM AUTHOR]
- Published
- 1999
- Full Text
- View/download PDF
11. Detection of antigens in mycelial and in arthroconidial phases of Trichophyton mentagrophytes.
- Author
-
Kopeček, P., Weigl, E., and Raška, M.
- Abstract
Protein pattern changes were investigated in the filamentous fungus Trichophyton mentagrophytes during the morphological transition induced by increased temperature and higher CO
2 partial pressure in cultivation atmosphere. The differences between the mycelial and the arthroconidial phase were characterized by SDS-PAGE and by immunodetection with mouse polyclonal antibodies. The components found by Western blotting in mycelia were 88, 86, 32, 29, 19.5, 18.5 kDa, in arthroconidia 108, 92, 88, 66, 56, 41, 39, 19.5 kDa. The results suggest the participation of some heat shock associated proteins of T. mentagrophytes in host immune response against mycotic infection. [ABSTRACT FROM AUTHOR]- Published
- 1998
- Full Text
- View/download PDF
12. Induction of humoral immune responses in the genital tract
- Author
-
Mestecky, J., Moldoveanu, Z., Alexander, R.C., and Raska, M.
- Published
- 2009
- Full Text
- View/download PDF
13. Human IL-22 receptor-targeted small protein antagonist suppress murine DSS-induced colitis.
- Author
-
Kuchař M, Sloupenská K, Rašková Kafková L, Groza Y, Škarda J, Kosztyu P, Hlavničková M, Mierzwicka JM, Osička R, Petroková H, Walimbwa SI, Bharadwaj S, Černý J, Raška M, and Malý P
- Subjects
- Animals, Humans, Mice, HEK293 Cells, Mice, Inbred C57BL, Interleukin-22, Disease Models, Animal, Interleukins genetics, Interleukins metabolism, Colitis chemically induced, Colitis pathology, Colitis metabolism, Dextran Sulfate, Receptors, Interleukin metabolism, Receptors, Interleukin genetics
- Abstract
Background: Human interleukin-22 (IL-22) is known as a "dual function" cytokine that acts as a master regulator to maintain homeostasis, structural integrity of the intestinal epithelial barrier, and shielding against bacterial pathogens. On the other hand, the overexpression of IL-22 is associated with hyper-proliferation and recruitment of pathologic effector cells, leading to tissue damage and chronic inflammation in specific diseases including inflammatory bowel disease (IBD). To study a role of IL-22-mediated signaling axis during intestinal inflammation, we generated a set of small protein blockers of IL-22R1 and verified their inhibitory potential on murine model of colitis., Methods: We used directed evolution of proteins to identify binders of human IL-22 receptor alpha (IL-22R1), designated as ABR ligands. This approach combines the assembly of a highly complex combinatorial protein library derived from small albumin-binding domain scaffold and selection of promising protein variants using ribosome display followed by large-scale ELISA screening. The binding affinity and specificity of ABR variants were analyzed on transfected HEK293T cells by flow cytometry and LigandTracer. Inhibitory function was further verified by competition ELISA, HEK-Blue IL-22 reporter cells, and murine dextran sulfate sodium (DSS)-induced colitis., Results: We demonstrate that ABR specifically recognizes transgenic IL-22R1 expressed on HEK293T cells and IL-22R1 on TNFα/IFNγ-activated HaCaT cells. Moreover, some ABR binders compete with the IL-22 cytokine and function as IL-22R1 antagonists in HEK-Blue IL22 reporter cells. In a murine model of DSS-induced acute intestinal inflammation, daily intraperitoneal administration of the best IL-22R1 antagonist, ABR167, suppressed the development of clinical and histological markers of colitis including prevention of mucosal inflammation and architecture deterioration. In addition, ABR167 reduces the DSS-induced increase in mRNA transcript levels of inflammatory cytokines such as IL-1β, IL-6, IL-10, and IL-17A., Conclusions: We developed small anti-human IL-22R1 blockers with antagonistic properties that ascertain a substantial role of IL-22-mediated signaling in the development of intestinal inflammation. The developed ABR blockers can be useful as a molecular clue for further IBD drug development., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
14. Long circulating liposomal platform utilizing hydrophilic polymer-based surface modification: preparation, characterisation, and biological evaluation.
- Author
-
Turánek J, Kosztyu P, Turánek Knötigová P, Bartheldyová E, Hubatka F, Odehnalová N, Mikulík R, Vaškovicová N, Čelechovská H, Kratochvílová I, Fekete L, Tavares MR, Chytil P, Raška M, and Etrych T
- Subjects
- Animals, Rabbits, Mice, Humans, Complement Activation drug effects, Acrylamides chemistry, Cholesterol chemistry, Cholesterol blood, Drug Delivery Systems, Male, Polymers chemistry, Liposomes, Hydrophobic and Hydrophilic Interactions, Polyethylene Glycols chemistry, Surface Properties
- Abstract
Liposomes are one of the most important drug delivery vectors, nowadays used in clinics. In general, polyethylene glycol (PEG) is used to ensure the stealth properties of the liposomes. Here, we have employed hydrophilic, biocompatible and highly non-fouling N-(2-hydroxypropyl) methacrylamide (HPMA)-based copolymers containing hydrophobic cholesterol anchors for the surface modification of liposomes, which were prepared by the method of lipid film hydration and extrusion through 100 nm polycarbonate filters. Efficient surface modification of liposomes was confirmed by transmission electron microscopy, atomic force microscopy, and gradient ultracentrifugation. The ability of long-term circulation in the vascular bed was demonstrated in rabbits after i.v. application of fluorescently labelled liposomes. Compared to PEGylated liposomes, HPMA-based copolymer-modified liposomes did not induce specific antibody formation and did not activate murine and human complement. Compared with PEGylated liposomes, HPMA-based copolymer-modified liposomes showed a better long-circulating effect after repeated administration. HPMA-based copolymer-modified liposomes thus represent suitable new candidates for a generation of safer and improved liposomal drug delivery platforms., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
15. Prognostic relevance of the C-X-C motif chemokine ligand 13 and interleukin-8 in predicting the transition from clinically isolated syndrome to multiple sclerosis.
- Author
-
Klíčová K, Mareš J, Sobek O, Rous Z, Rous M, Raška M, and Hartung HP
- Subjects
- Humans, Female, Male, Adult, Prognosis, Biomarkers cerebrospinal fluid, Biomarkers blood, Middle Aged, Demyelinating Diseases cerebrospinal fluid, Multiple Sclerosis cerebrospinal fluid, Multiple Sclerosis blood, Multiple Sclerosis diagnosis, Young Adult, Chemokine CXCL13 cerebrospinal fluid, Chemokine CXCL13 blood, Interleukin-8 cerebrospinal fluid, Interleukin-8 blood, Disease Progression, Multiple Sclerosis, Relapsing-Remitting cerebrospinal fluid, Multiple Sclerosis, Relapsing-Remitting blood, Multiple Sclerosis, Relapsing-Remitting diagnosis
- Abstract
The initial phase of multiple sclerosis (MS), often known as clinically isolated syndrome (CIS), is a critical period for identifying individuals at high risk of progressing to full-blown MS and initiating timely treatment. In this study, we aimed to evaluate the prognostic value of C-X-C motif chemokine ligand 13 (CXCL13) and interleukin-8 (IL-8) as potential markers for CIS patients' conversion to MS. Our study encompassed patients with CIS, those with relapsing-remitting MS (RRMS), and control subjects, with sample analysis conducted on both cerebrospinal fluid (CSF) and serum. Patients were categorized into four groups: CIS-CIS (no MS development within 2 years), CIS-RRMS (conversion to RRMS within 2 years), RRMS (already diagnosed), and a control group (CG) with noninflammatory central nervous system disorders. Results showed significantly elevated levels of CXCL13 in CSF across all patient groups compared with the CG (p < 0.0001, Kruskal-Wallis test). Although CXCL13 concentrations were slightly higher in the CIS-RRMS group, statistical significance was not reached. Similarly, significantly higher levels of IL-8 were detected in CSF samples from all patient groups compared with the CG (p < 0.0001, Kruskal-Wallis test). Receiver operating characteristic analysis in the CIS-RRMS group identified both CXCL13 (area under receiver operating characteristic curve = .959) and IL-8 (area under receiver operating characteristic curve = .939) in CSF as significant predictors of CIS to RRMS conversion. In conclusion, our study suggests a trend towards elevated CSF IL-8 and CSF CXCL13 levels in CIS patients progressing to RRMS. These findings emphasize the importance of identifying prognostic markers to guide appropriate treatment strategies for individuals in the early stages of MS., (© 2024 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
16. Small protein blockers of human IL-6 receptor alpha inhibit proliferation and migration of cancer cells.
- Author
-
Groza Y, Lacina L, Kuchař M, Rašková Kafková L, Zachová K, Janoušková O, Osička R, Černý J, Petroková H, Mierzwicka JM, Panova N, Kosztyu P, Sloupenská K, Malý J, Škarda J, Raška M, Smetana K Jr, and Malý P
- Subjects
- Humans, HEK293 Cells, Cell Line, Tumor, Protein Binding drug effects, Cell Proliferation drug effects, Receptors, Interleukin-6 metabolism, Cell Movement drug effects
- Abstract
Background: Interleukin-6 (IL-6) is a multifunctional cytokine that controls the immune response, and its role has been described in the development of autoimmune diseases. Signaling via its cognate IL-6 receptor (IL-6R) complex is critical in tumor progression and, therefore, IL-6R represents an important therapeutic target., Methods: An albumin-binding domain-derived highly complex combinatorial library was used to select IL-6R alpha (IL-6Rα)-targeted small protein binders using ribosome display. Large-scale screening of bacterial lysates of individual clones was performed using ELISA, and their IL-6Rα blocking potential was verified by competition ELISA. The binding of proteins to cells was monitored by flow cytometry and confocal microscopy on HEK293T-transfected cells, and inhibition of signaling function was examined using HEK-Blue IL-6 reporter cells. Protein binding kinetics to living cells was measured by LigandTracer, cell proliferation and toxicity by iCELLigence and Incucyte, cell migration by the scratch wound healing assay, and prediction of binding poses using molecular modeling by docking., Results: We demonstrated a collection of protein variants called NEF ligands, selected from an albumin-binding domain scaffold-derived combinatorial library, and showed their binding specificity to human IL-6Rα and antagonistic effect in HEK-Blue IL-6 reporter cells. The three most promising NEF108, NEF163, and NEF172 variants inhibited cell proliferation of malignant melanoma (G361 and A2058) and pancreatic (PaTu and MiaPaCa) cancer cells, and suppressed migration of malignant melanoma (A2058), pancreatic carcinoma (PaTu), and glioblastoma (GAMG) cells in vitro. The NEF binders also recognized maturation-induced IL-6Rα expression and interfered with IL-6-induced differentiation in primary human B cells., Conclusion: We report on the generation of small protein blockers of human IL-6Rα using directed evolution. NEF proteins represent a promising class of non-toxic anti-tumor agents with migrastatic potential., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
17. Engineering PD-1-targeted small protein variants for in vitro diagnostics and in vivo PET imaging.
- Author
-
Mierzwicka JM, Petroková H, Kafková LR, Kosztyu P, Černý J, Kuchař M, Petřík M, Bendová K, Krasulová K, Groza Y, Vaňková L, Bharadwaj S, Panova N, Křupka M, Škarda J, Raška M, and Malý P
- Subjects
- Humans, Animals, HEK293 Cells, Mice, Carcinoma, Non-Small-Cell Lung diagnostic imaging, Carcinoma, Non-Small-Cell Lung pathology, Carcinoma, Non-Small-Cell Lung metabolism, Cell Line, Tumor, Lung Neoplasms diagnostic imaging, Lung Neoplasms pathology, Lung Neoplasms metabolism, Lung Neoplasms genetics, Amino Acid Sequence, Programmed Cell Death 1 Receptor metabolism, Positron-Emission Tomography methods, Protein Engineering
- Abstract
Background: Programmed cell death 1 (PD-1) belongs to immune checkpoint proteins ensuring negative regulation of the immune response. In non-small cell lung cancer (NSCLC), the sensitivity to treatment with anti-PD-1 therapeutics, and its efficacy, mostly correlated with the increase of tumor infiltrating PD-1
+ lymphocytes. Due to solid tumor heterogeneity of PD-1+ populations, novel low molecular weight anti-PD-1 high-affinity diagnostic probes can increase the reliability of expression profiling of PD-1+ tumor infiltrating lymphocytes (TILs) in tumor tissue biopsies and in vivo mapping efficiency using immune-PET imaging., Methods: We designed a 13 kDa β-sheet Myomedin scaffold combinatorial library by randomization of 12 mutable residues, and in combination with ribosome display, we identified anti-PD-1 Myomedin variants (MBA ligands) that specifically bound to human and murine PD-1-transfected HEK293T cells and human SUP-T1 cells spontaneously overexpressing cell surface PD-1., Results: Binding affinity to cell-surface expressed human and murine PD-1 on transfected HEK293T cells was measured by fluorescence with LigandTracer and resulted in the selection of most promising variants MBA066 (hPD-1 KD = 6.9 nM; mPD-1 KD = 40.5 nM), MBA197 (hPD-1 KD = 29.7 nM; mPD-1 KD = 21.4 nM) and MBA414 (hPD-1 KD = 8.6 nM; mPD-1 KD = 2.4 nM). The potential of MBA proteins for imaging of PD-1+ populations in vivo was demonstrated using deferoxamine-conjugated MBA labeled with68 Galium isotope. Radiochemical purity of68 Ga-MBA proteins reached values 94.7-99.3% and in vitro stability in human serum after 120 min was in the range 94.6-98.2%. The distribution of68 Ga-MBA proteins in mice was monitored using whole-body positron emission tomography combined with computerized tomography (PET/CT) imaging up to 90 min post-injection and post mortem examined in 12 mouse organs. The specificity of MBA proteins was proven by co-staining frozen sections of human tonsils and NSCLC tissue biopsies with anti-PD-1 antibody, and demonstrated their potential for mapping PD-1+ populations in solid tumors., Conclusions: Using directed evolution, we developed a unique set of small binding proteins that can improve PD-1 diagnostics in vitro as well as in vivo using PET/CT imaging., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
18. COVID-19: to vaccinate or not to vaccinate - that is the question.
- Author
-
Městecký J and Raška M
- Subjects
- Humans, Vaccination, Immunity, Mucosal, COVID-19 prevention & control, COVID-19 immunology, COVID-19 Vaccines immunology, SARS-CoV-2 immunology
- Abstract
SARS-CoV-2 is a virus which infects the respiratory tract and may cause severe, occasionally life-threatening disease COVID-19. In more than 5% of symptomatic patients the infection is associated with post-acute symptoms. The initial contact of the virus with the immune system of the nasopharynx and oropharynx induces a mucosal immune response manifested by the production of secretory IgA (sIgA) antibodies which may contribute to the restriction of the infection to the upper respiratory tract and an asymptomatic or clinically mild disease. The current systemically administered vaccines protected against the severe COVID-19 infection and its post-acute sequelae. However, they do not induce antibodies in mucosal secretions in SARS-CoV-2-naive individuals. In contrast, in those who previously experienced mucosal infection, systemically administered vaccines may stimulate sIgA production. The clinical benefit of systemic vaccination convincingly documented in tens of millions of individuals overshadows the rare, sometimes controversial reports of complications encountered after vaccination. The inability of current SARS-CoV-2 vaccines to induce mucosal immune responses and to prevent the spreading of the virus by external secretions demonstrates the mutual independence of mucosal and systemic compartments of the immune system, and thus emphasizes need for the development of vaccines inducing protective immune responses in both compartments.
- Published
- 2024
19. Potential predictors of immunotherapy in small cell lung cancer.
- Author
-
Skopelidou V, Strakoš J, Škarda J, Raška M, and Kafková-Rašková L
- Subjects
- Humans, Prospective Studies, Immunotherapy methods, Biomarkers, Tumor metabolism, Tumor Microenvironment, Small Cell Lung Carcinoma genetics, Lung Neoplasms genetics
- Abstract
Lung cancer is one of the leading causes of cancer-related deaths worldwide, with small cell lung cancer (SCLC) having the worst prognosis. SCLC is diagnosed late in the disease's progression, limiting treatment options. The most common treatment for SCLC is chemotherapy. As the disease progresses, immunotherapy, most commonly checkpoint inhibitor medication, becomes more important. Efforts should be made in the development of immunotherapy to map specific biomarkers, which play a role in properly assigning a type of immunotherapy to the right cohort of patients, where the benefits outweigh any risks or adverse effects. The objective of this review was to provide a thorough assessment of current knowledge about the nature of the tumor process and treatment options for small cell lung cancer, with a focus on predictive biomarkers. According to the information obtained, the greatest potential, which has already been directly demonstrated in some studies, has characteristics such as tumor microenvironment composition, tumor mutation burden, and molecular subtyping of SCLC. Several other aspects appear to be promising, but more research, particularly prospective studies on a larger number of probands, is required. However, it is clear that this field of study will continue to expand, as developing a reliable method to predict immunotherapy response is a very appealing goal of current medicine and research in the field of targeted cancer therapy., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Skopelidou, Strakoš, Škarda, Raška and Kafková-Rašková.)
- Published
- 2023
- Full Text
- View/download PDF
20. Myomedin replicas of gp120 V3 loop glycan epitopes recognized by PGT121 and PGT126 antibodies as non-cognate antigens for stimulation of HIV-1 broadly neutralizing antibodies.
- Author
-
Daniel Lišková V, Kosztyu P, Kuchař M, Černý J, Bharadwaj S, Petroková H, Vroblová E, Křupka M, Malý M, Zosinčuková T, Šulc J, Rašková Kafková L, Raška M, and Malý P
- Subjects
- Animals, Mice, Epitopes, Broadly Neutralizing Antibodies, Antibodies, Neutralizing, HIV Envelope Protein gp120, Polysaccharides, HIV Antibodies, HIV-1
- Abstract
Introduction: Imprinting broadly neutralizing antibody (bNAb) paratopes by shape complementary protein mimotopes represents a potential alternative for developing vaccine immunogens. This approach, designated as a Non-Cognate Ligand Strategy (NCLS), has recently been used for the identification of protein variants mimicking CD4 binding region epitope or membrane proximal external region (MPER) epitope of HIV-1 envelope (Env) glycoprotein. However, the potential of small binding proteins to mimic viral glycan-containing epitopes has not yet been verified., Methods: In this work, we employed a highly complex combinatorial Myomedin scaffold library to identify variants recognizing paratopes of super candidate bNAbs, PGT121 and PGT126, specific for HIV-1 V3 loop epitopes., Results: In the collection of Myomedins called MLD variants targeted to PGT121, three candidates competed with gp120 for binding to this bNAb in ELISA, thus suggesting an overlapping binding site and epitope-mimicking potential. Myomedins targeted to PGT126 designated MLB also provided variants that competed with gp120. Immunization of mice with MLB or MLD binders resulted in the production of anti-gp120 and -Env serum antibodies. Mouse hyper-immune sera elicited with MLB036, MLB041, MLB049, and MLD108 moderately neutralized 8-to-10 of 22 tested HIV-1-pseudotyped viruses of A, B, and C clades in vitro ., Discussion: Our data demonstrate that Myomedin-derived variants can mimic particular V3 glycan epitopes of prominent anti-HIV-1 bNAbs, ascertain the potential of particular glycans controlling neutralizing sensitivity of individual HIV-1 pseudoviruses, and represent promising prophylactic candidates for HIV-1 vaccine development., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Daniel Lišková, Kosztyu, Kuchař, Černý, Bharadwaj, Petroková, Vroblová, Křupka, Malý, Zosinčuková, Šulc, Rašková Kafková, Raška and Malý.)
- Published
- 2022
- Full Text
- View/download PDF
21. Distinguishing Invasive from Chronic Pulmonary Infections: Host Pentraxin 3 and Fungal Siderophores in Bronchoalveolar Lavage Fluids.
- Author
-
Dobiáš R, Jaworská P, Skopelidou V, Strakoš J, Višňovská D, Káňová M, Škríba A, Lysková P, Bartek T, Janíčková I, Kozel R, Cwiková L, Vrba Z, Navrátil M, Martinek J, Coufalová P, Krejčí E, Ulmann V, Raška M, Stevens DA, and Havlíček V
- Abstract
The multiple forms of pulmonary aspergillosis caused by Aspergillus species are the most common respiratory mycoses. Although invasive, the analysis of diagnostic biomarkers in bronchoalveolar lavage fluid (BALF) is a clinical standard for diagnosing these conditions. The BALF samples from 22 patients with proven or probable aspergillosis were assayed for human pentraxin 3 (Ptx3), fungal ferricrocin (Fc), and triacetylfusarinine C (TafC) in a retrospective study. The infected group included patients with invasive pulmonary aspergillosis (IPA) and chronic aspergillosis (CPA). The BALF data were compared to a control cohort of 67 patients with invasive pulmonary mucormycosis (IPM), non-Aspergillus colonization, or bacterial infections. The median Ptx3 concentrations in patients with and without aspergillosis were 4545.5 and 242.0 pg/mL, respectively (95% CI, p < 0.05). The optimum Ptx3 cutoff for IPA was 2545 pg/mL, giving a sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 100, 98, 95, and 100%, respectively. The median Ptx3 concentration for IPM was high at 4326 pg/mL. Pentraxin 3 assay alone can distinguish IPA from CPA and invasive fungal disease from colonization. Combining Ptx3 and TafC assays enabled the diagnostic discrimination of IPM and IPA, giving a specificity and PPV of 100%.
- Published
- 2022
- Full Text
- View/download PDF
22. Combined Use of Presepsin and (1,3)-β-D-glucan as Biomarkers for Diagnosing Candida Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients.
- Author
-
Dobiáš R, Káňová M, Petejová N, Pisti ŠK, Bocek R, Krejčí E, Stružková H, Cachová M, Tomášková H, Hamal P, Havlíček V, and Raška M
- Abstract
New biomarker panel was developed and validated on 165 critically ill adult patients to enable a more accurate invasive candidiasis (IC) diagnosis. Serum levels of the panfungal biomarker (1,3)-β-D-glucan (BDG) and the inflammatory biomarkers C-reactive protein, presepsin (PSEP), and procalcitonin (PCT) were correlated with culture-confirmed candidemia or bacteremia in 58 and 107 patients, respectively. The diagnostic utility was evaluated in sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). BDG was the best marker for IC, achieving 96.6% sensitivity, 97.2% specificity, 94.9% PPV, and 98.1% NPV at a cut-off of 200 pg/mL (p ≤ 0.001). PSEP exhibited 100% sensitivity and 100% NPV at a cut-off of 700 pg/mL but had a lower PPV (36.5%) and low specificity (5.6%). Combined use of PSEP and BDG, thus, seems to be the most powerful laboratory approach for diagnosing IC. Furthermore, PSEP was more accurate for 28-day mortality prediction the area under the receiver operating characteristic curve (AUC = 0.74) than PCT (AUC = 0.31; PCT cut-off = 0.5 ng/mL). Finally, serum PSEP levels decreased significantly after only 14 days of echinocandin therapy (p = 0.0012). The probability of IC is almost 100% in critically ill adults with serum BDG and PSEP concentrations > 200 pg/mL and >700 pg/mL, respectively, defining a borderline between non-invasive superficial Candida colonization and IC.
- Published
- 2022
- Full Text
- View/download PDF
23. Myomedin scaffold variants targeted to 10E8 HIV-1 broadly neutralizing antibody mimic gp41 epitope and elicit HIV-1 virus-neutralizing sera in mice.
- Author
-
Kuchař M, Kosztyu P, Daniel Lišková V, Černý J, Petroková H, Vróblová E, Malý M, Vaňková L, Křupka M, Rašková Kafková L, Turánek Knotigová P, Dušková J, Dohnálek J, Mašek J, Turánek J, Raška M, and Malý P
- Subjects
- Animals, Antibodies, Neutralizing, Broadly Neutralizing Antibodies, Epitopes, HIV Antibodies, Mice, Viral Pseudotyping, env Gene Products, Human Immunodeficiency Virus genetics, HIV Infections prevention & control, HIV-1 genetics
- Abstract
One of the proposed strategies for the development of a more efficient HIV-1 vaccine is based on the identification of proteins binding to a paratope of chosen broadly neutralizing antibody (bNAb) that will mimic cognate HIV-1 Env (glyco)protein epitope and could be used as potent immunogens for induction of protective virus-neutralizing antibodies in the immunized individuals. To verify this "non-cognate ligand" concept, we developed a highly complex combinatorial library designed on a scaffold of human myomesin-1 protein domain and selected proteins called Myomedins specifically binding to variable regions of HIV-1 broadly neutralizing antibody 10E8. Immunization of mice with these Myomedin variants elicited the production of HIV-1 Env-specific antibodies. Hyperimmune sera bound to Env pseudotyped viruses and weakly/moderately neutralized 54% of tested clade A, B, C, and AE pseudotyped viruses variants in vitro . These results demonstrate that Myomedin variants have the potential to mimic Env epitopes and could be used as potential HIV-1 vaccine components.
- Published
- 2021
- Full Text
- View/download PDF
24. Short-course sublingual immunotherapy by mucoadhesive patch and tolerogenic particle enhanced allergen presentation.
- Author
-
Sørensen P, Turánek-Knotigová P, Mašek J, Kotouček J, Hubatka F, Mašková E, Kulich P, Lubasová D, Raška M, Leenhouts K, and Turánek J
- Subjects
- Administration, Mucosal, Allergens immunology, Animals, Drug Delivery Systems, Immune Tolerance, Mouth Floor, Ovalbumin immunology, Swine, Allergens administration & dosage, Ovalbumin administration & dosage, Sublingual Immunotherapy methods
- Published
- 2021
- Full Text
- View/download PDF
25. Overexpression of CD44v8-10 in Colon Polyps-A Possible Key to Early Diagnosis.
- Author
-
Dastych M, Hubatka F, Turanek-Knotigova P, Masek J, Kroupa R, Raška M, Turanek J, and Prochazka L
- Subjects
- Biomarkers, Tumor genetics, Colon metabolism, Colonic Polyps metabolism, Colorectal Neoplasms genetics, Colorectal Neoplasms metabolism, Humans, Hyaluronan Receptors genetics, Prognosis, Protein Isoforms, Biomarkers, Tumor metabolism, Colon pathology, Colonic Polyps pathology, Colorectal Neoplasms diagnosis, Hyaluronan Receptors metabolism
- Abstract
Background and aims: The majority of colorectal cancers arise from detectable adenomatous or serrated lesions. Here we demonstrate how deregulated alternative splicing of CD44 gene in diseased colon mucosa results in downregulation of standard isoform of CD44 gene (CD44s) and upregulation of variant isoform CD44v8-10. Our aim is to show that upregulation of CD44v8-10 isoform is a possible marker of precancerous lesion in human colon. Methods: We analysed pairs of fresh biopsy specimen of large intestine in a cohort of 50 patients. We studied and compared alternative splicing profile of CD44 gene in colon polyps and adjoined healthy colon mucosa. We performed end-point and qRT PCR, western blotting, IHC staining and flow cytometry analyses. Results: We detected more than five-fold overexpression of CD44v8-10 isoform and almost twenty-fold downregulation of standard isoform CD44s in colon polyps compared to adjoined healthy tissue with p = 0.018 and p < 0.001 in a cohort of 50 patients. Our results also show that aberrant splicing of CD44 occurs in both biologically distinct subtypes of colorectal adenoma possibly in ESRP-1 specific manner. Conclusion: 92% of the colon polyp positive patients overexpressed CD44v8-10 isoform in their colon polyps while only 36% of them had positive fecal occult blood test which is currently a standard non-invasive screening technique. Impact: We believe that our results are important for further steps leading to application of CD44v8-10 isoform as a biomarker of colorectal precancerosis in non-invasive detection. Early detection of colon precancerosis means successful prevention of colorectal carcinoma., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Dastych, Hubatka, Turanek-Knotigova, Masek, Kroupa, Raška, Turanek and Prochazka.)
- Published
- 2021
- Full Text
- View/download PDF
26. Preparation of nanoliposomes by microfluidic mixing in herring-bone channel and the role of membrane fluidity in liposomes formation.
- Author
-
Kotouček J, Hubatka F, Mašek J, Kulich P, Velínská K, Bezděková J, Fojtíková M, Bartheldyová E, Tomečková A, Stráská J, Hrebík D, Macaulay S, Kratochvílová I, Raška M, and Turánek J
- Subjects
- Biocompatible Materials metabolism, Cholestyramine Resin metabolism, Fluorescence Polarization, Lab-On-A-Chip Devices, Microfluidics instrumentation, Liposomes chemical synthesis, Membrane Fluidity, Microfluidics methods, Nanostructures
- Abstract
Introduction of microfluidic mixing technique opens a new door for preparation of the liposomes and lipid-based nanoparticles by on-chip technologies that are applicable in a laboratory and industrial scale. This study demonstrates the role of phospholipid bilayer fragment as the key intermediate in the mechanism of liposome formation by microfluidic mixing in the channel with "herring-bone" geometry used with the instrument NanoAssemblr. The fluidity of the lipid bilayer expressed as fluorescence anisotropy of the probe N,N,N-Trimethyl-4-(6-phenyl-1,3,5-hexatrien-1-yl) was found to be the basic parameter affecting the final size of formed liposomes prepared by microfluidic mixing of an ethanol solution of lipids and water phase. Both saturated and unsaturated lipids together with various content of cholesterol were used for liposome preparation and it was demonstrated, that an increase in fluidity results in a decrease of liposome size as analyzed by DLS. Gadolinium chelating lipids were used to visualize the fine structure of liposomes and bilayer fragments by CryoTEM. Experimental data and theoretical calculations are in good accordance with the theory of lipid disc micelle vesiculation.
- Published
- 2020
- Full Text
- View/download PDF
27. Gadolinium labelled nanoliposomes as the platform for MRI theranostics: in vitro safety study in liver cells and macrophages.
- Author
-
Šimečková P, Hubatka F, Kotouček J, Turánek Knötigová P, Mašek J, Slavík J, Kováč O, Neča J, Kulich P, Hrebík D, Stráská J, Pěnčíková K, Procházková J, Diviš P, Macaulay S, Mikulík R, Raška M, Machala M, and Turánek J
- Subjects
- Cells, Cultured, Fibrinolytic Agents, Humans, Inflammasomes, NLR Family, Pyrin Domain-Containing 3 Protein, Nanoparticles, Contrast Media, Drug Carriers, Gadolinium DTPA adverse effects, Gadolinium DTPA toxicity, Hepatocytes drug effects, Liposomes, Macrophages drug effects, Magnetic Resonance Imaging, Phosphatidylethanolamines adverse effects, Phosphatidylethanolamines toxicity
- Abstract
Gadolinium (Gd)-based contrast agents are extensively used for magnetic resonance imaging (MRI). Liposomes are potential nanocarrier-based biocompatible platforms for development of new generations of MRI diagnostics. Liposomes with Gd-complexes (Gd-lip) co-encapsulated with thrombolytic agents can serve both for imaging and treatment of various pathological states including stroke. In this study, we evaluated nanosafety of Gd-lip containing PE-DTPA chelating Gd
+3 prepared by lipid film hydration method. We detected no cytotoxicity of Gd-lip in human liver cells including cancer HepG2, progenitor (non-differentiated) HepaRG, and differentiated HepaRG cells. Furthermore, no potential side effects of Gd-lip were found using a complex system including general biomarkers of toxicity, such as induction of early response genes, oxidative, heat shock and endoplasmic reticulum stress, DNA damage responses, induction of xenobiotic metabolizing enzymes, and changes in sphingolipid metabolism in differentiated HepaRG. Moreover, Gd-lip did not show pro-inflammatory effects, as assessed in an assay based on activation of inflammasome NLRP3 in a model of human macrophages, and release of eicosanoids from HepaRG cells. In conclusion, this in vitro study indicates potential in vivo safety of Gd-lip with respect to hepatotoxicity and immunopathology caused by inflammation.- Published
- 2020
- Full Text
- View/download PDF
28. Targeting Human Thrombus by Liposomes Modified with Anti-Fibrin Protein Binders.
- Author
-
Petroková H, Mašek J, Kuchař M, Vítečková Wünschová A, Štikarová J, Bartheldyová E, Kulich P, Hubatka F, Kotouček J, Knotigová PT, Vohlídalová E, Héžová R, Mašková E, Macaulay S, Dyr JE, Raška M, Mikulík R, Malý P, and Turánek J
- Abstract
Development of tools for direct thrombus imaging represents a key step for diagnosis and treatment of stroke. Nanoliposomal carriers of contrast agents and thrombolytics can be functionalized to target blood thrombi by small protein binders with selectivity for fibrin domains uniquely formed on insoluble fibrin. We employed a highly complex combinatorial library derived from scaffold of 46 amino acid albumin-binding domain (ABD) of streptococcal protein G, and ribosome display, to identify variants recognizing fibrin cloth in human thrombus. We constructed a recombinant target as a stretch of three identical fibrin fragments of 16 amino acid peptide of the Bβ chain fused to TolA protein. Ribosome display selection followed by large-scale Enzyme-Linked ImmunoSorbent Assay (ELISA) screening provided four protein variants preferentially binding to insoluble form of human fibrin. The most specific binder variant D7 was further modified by C-terminal FLAG/His-Tag or double His-tag for the attachment onto the surface of nanoliposomes via metallochelating bond. D7-His-nanoliposomes were tested using in vitro flow model of coronary artery and their binding to fibrin fibers was demonstrated by confocal and electron microscopy. Thus, we present here the concept of fibrin-targeted binders as a platform for functionalization of nanoliposomes in the development of advanced imaging tools and future theranostics.
- Published
- 2019
- Full Text
- View/download PDF
29. Application of Advanced Microscopic Methods to Study the Interaction of Carboxylated Fluorescent Nanodiamonds with Membrane Structures in THP-1 Cells: Activation of Inflammasome NLRP3 as the Result of Lysosome Destabilization.
- Author
-
Knötigová PT, Mašek J, Hubatka F, Kotouček J, Kulich P, Šimečková P, Bartheldyová E, Machala M, Švadláková T, Krejsek J, Vaškovicová N, Skoupý R, Krzyžánek V, Macaulay S, Katzuba M, Fekete L, Ashcheulov P, Raška M, Kratochvílová I, and Turánek J
- Subjects
- Cathepsin B immunology, Cathepsin B metabolism, Cell Membrane drug effects, Cell Membrane metabolism, Cell Membrane ultrastructure, Dynamic Light Scattering, Fluorescence, Humans, Inflammasomes immunology, Inflammasomes metabolism, Lysosomes immunology, Lysosomes metabolism, Lysosomes ultrastructure, Microscopy, Atomic Force, Microscopy, Confocal, Microscopy, Electron, NLR Family, Pyrin Domain-Containing 3 Protein immunology, Nanodiamonds chemistry, Pinocytosis, THP-1 Cells, Inflammasomes drug effects, Intravital Microscopy methods, Lysosomes drug effects, NLR Family, Pyrin Domain-Containing 3 Protein metabolism, Nanodiamonds administration & dosage
- Abstract
Nanodiamonds (ND), especially fluorescent NDs, represent potentially applicable drug and probe carriers for in vitro/in vivo applications. The main purpose of this study was to relate physical-chemical properties of carboxylated NDs to their intracellular distribution and impact on membranes and cell immunity-activation of inflammasome in the in vitro THP-1 cell line model. Dynamic light scattering, nanoparticle tracking analysis, and microscopic methods were used to characterize ND particles and their intracellular distribution. Fluorescent NDs penetrated the cell membranes by both macropinocytosis and mechanical cutting through cell membranes. We proved accumulation of fluorescent NDs in lysosomes. In this case, lysosomes were destabilized and cathepsin B was released into the cytoplasm and triggered pathways leading to activation of inflammasome NLRP3, as detected in THP-1 cells. Activation of inflammasome by NDs represents an important event that could underlie the described toxicological effects in vivo induced by NDs. According to our knowledge, this is the first in vitro study demonstrating direct activation of inflammasome by NDs. These findings are important for understanding the mechanism(s) of action of ND complexes and explain the ambiguity of the existing toxicological data.
- Published
- 2019
- Full Text
- View/download PDF
30. N-Oxy lipid-based click chemistry for orthogonal coupling of mannan onto nanoliposomes prepared by microfluidic mixing: Synthesis of lipids, characterisation of mannan-coated nanoliposomes and in vitro stimulation of dendritic cells.
- Author
-
Bartheldyová E, Turánek Knotigová P, Zachová K, Mašek J, Kulich P, Effenberg R, Zyka D, Hubatka F, Kotouček J, Čelechovská H, Héžová R, Tomečková A, Mašková E, Fojtíková M, Macaulay S, Bystrický P, Paulovičová L, Paulovičová E, Drož L, Ledvina M, Raška M, and Turánek J
- Subjects
- Adjuvants, Immunologic pharmacology, Animals, Antigens, Surface metabolism, Candida glabrata chemistry, Click Chemistry, Humans, Hydroxylamines chemical synthesis, Hydroxylamines chemistry, Lipids chemical synthesis, Lipids chemistry, Liposomes chemistry, Liposomes pharmacology, Mannans chemistry, Mannans pharmacology, Mannose Receptor, Mice, Inbred BALB C, Microfluidics methods, Particle Size, Dendritic Cells immunology, Lectins, C-Type immunology, Liposomes immunology, Mannans immunology, Mannose-Binding Lectins immunology, Nanoparticles chemistry, Receptors, Cell Surface immunology
- Abstract
New synthetic aminooxy lipid was designed and synthesized as a building block for the formulation of functionalised nanoliposomes (presenting onto the outer surface of aminooxy groups) by microfluidic mixing. Orthogonal binding of cellular mannan (Candida glabrata (CCY 26-20-1) onto the outer surface of functionalised nanoliposomes was modified by orthogonal binding of reducing termini of mannans to oxime lipids via a click chemistry reaction based on aminooxy coupling (oxime ligation). The aminooxy lipid was proved as a suitable active component for preparation of functionalised nanoliposomes by the microfluidic mixing method performed with the instrument NanoAssemblr™. This "on-chip technology" can be easily scaled-up. The structure of mannan-liposomes was visualized by transmission and scanning electron microscopy, including immunogold staining of recombinant mannan receptor bound onto mannosylated-liposomes. The observed structures are in a good correlation with data obtained by DLS, NTA, and TPRS methods. In vitro experiments on human and mouse dendritic cells demonstrate selective internalisation of fluorochrome-labelled mannan-liposomes and their ability to stimulate DC comparable to lipopolysaccharide. We describe a potentially new drug delivery platform for mannan receptor-targeted antimicrobial drugs as well as for immunotherapeutics. Furthermore, the platform based on mannans bound orthogonally onto the surface of nanoliposomes represents a self-adjuvanted carrier for construction of liposome-based recombinant vaccines for both systemic and mucosal routes of administration., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
31. Hyaluronic Acid Surface Modified Liposomes Prepared via Orthogonal Aminoxy Coupling: Synthesis of Nontoxic Aminoxylipids Based on Symmetrically α-Branched Fatty Acids, Preparation of Liposomes by Microfluidic Mixing, and Targeting to Cancer Cells Expressing CD44.
- Author
-
Bartheldyová E, Effenberg R, Mašek J, Procházka L, Knötigová PT, Kulich P, Hubatka F, Velínská K, Zelníčková J, Zouharová D, Fojtíková M, Hrebík D, Plevka P, Mikulík R, Miller AD, Macaulay S, Zyka D, Drož L, Raška M, Ledvina M, and Turánek J
- Subjects
- Cell Line, Endocytosis, Fluorescent Dyes, Humans, Hyaluronan Receptors analysis, Hyaluronic Acid metabolism, Liposomes therapeutic use, Microfluidics, Microscopy, Electron, Transmission, Neoplasms drug therapy, Antineoplastic Agents administration & dosage, Drug Delivery Systems methods, Hyaluronan Receptors metabolism, Hyaluronic Acid chemistry, Lipids chemical synthesis, Liposomes chemistry
- Abstract
New synthetic aminoxy lipids are designed and synthesized as building blocks for the formulation of functionalized nanoliposomes by microfluidization using a NanoAssemblr. Orthogonal binding of hyaluronic acid onto the outer surface of functionalized nanoliposomes via aminoxy coupling ( N-oxy ligation) is achieved at hemiacetal function of hyaluronic acid and the structure of hyaluronic acid-liposomes is visualized by transmission electron microscopy and cryotransmission electron microscopy. Observed structures are in a good correlation with data obtained by dynamic light scattering (size and ζ-potential). In vitro experiments on cell lines expressing CD44 receptors demonstrate selective internalization of fluorochrome-labeled hyaluronic acid-liposomes, while cells with down regulated CD44 receptor levels exhibit very low internalization of hyaluronic acid-liposomes. A method based on microfluidization mixing was developed for preparation of monodispersive unilamellar liposomes containing aminoxy lipids and orthogonal binding of hyaluronic acid onto the liposomal surface was demonstrated. These hyaluronic acid-liposomes represent a potentially new drug delivery platform for CD44-targeted anticancer drugs as well as for immunotherapeutics and vaccines.
- Published
- 2018
- Full Text
- View/download PDF
32. Nonpyrogenic Molecular Adjuvants Based on norAbu-Muramyldipeptide and norAbu-Glucosaminyl Muramyldipeptide: Synthesis, Molecular Mechanisms of Action, and Biological Activities in Vitro and in Vivo.
- Author
-
Effenberg R, Turánek Knötigová P, Zyka D, Čelechovská H, Mašek J, Bartheldyová E, Hubatka F, Koudelka Š, Lukáč R, Kovalová A, Šaman D, Křupka M, Barkocziova L, Kosztyu P, Šebela M, Drož L, Hučko M, Kanásová M, Miller AD, Raška M, Ledvina M, and Turánek J
- Subjects
- Acetylmuramyl-Alanyl-Isoglutamine chemistry, Acetylmuramyl-Alanyl-Isoglutamine immunology, Adjuvants, Immunologic chemistry, Animals, Antibody Formation, Antigens, Surface chemistry, Antigens, Surface immunology, Bacterial Outer Membrane Proteins chemistry, Bacterial Outer Membrane Proteins immunology, Bacterial Vaccines chemistry, Bacterial Vaccines immunology, Female, HEK293 Cells, Humans, Immunization, Lipoproteins chemistry, Lipoproteins immunology, Lyme Disease immunology, Lyme Disease microbiology, Mice, Mice, Inbred BALB C, NLR Family, Pyrin Domain-Containing 3 Protein agonists, NLR Family, Pyrin Domain-Containing 3 Protein immunology, RAW 264.7 Cells, Acetylmuramyl-Alanyl-Isoglutamine analogs & derivatives, Acetylmuramyl-Alanyl-Isoglutamine pharmacology, Adjuvants, Immunologic pharmacology, Antigens, Surface pharmacology, Bacterial Outer Membrane Proteins pharmacology, Bacterial Vaccines pharmacology, Borrelia burgdorferi immunology, Lipoproteins pharmacology
- Abstract
Fatty acyl analogues of muramyldipeptide (MDP) (abbreviated N-L18 norAbuGMDP, N-B30 norAbuGMDP, norAbuMDP-Lys(L18), norAbuMDP-Lys(B30), norAbuGMDP-Lys(L18), norAbuGMDP-Lys(B30), B30 norAbuMDP, L18 norAbuMDP) are designed and synthesized comprising the normuramyl-l-α-aminobutanoyl (norAbu) structural moiety. All new analogues show depressed pyrogenicity in both free (micellar) state and in liposomal formulations when tested in rabbits in vivo (sc and iv application). New analogues are also shown to be selective activators of NOD2 and NLRP3 (inflammasome) in vitro but not NOD1. Potencies of NOD2 and NLRP3 stimulation are found comparable with free MDP and other positive controls. Analogues are also demonstrated to be effective in stimulating cellular proliferation when the sera from mice are injected sc with individual liposome-loaded analogues, causing proliferation of bone marrow-derived GM-progenitors cells. Importantly, vaccination nanoparticles prepared from metallochelation liposomes, His-tagged antigen rOspA from Borrelia burgdorferi, and lipophilic analogue norAbuMDP-Lys(B30) as adjuvant, are shown to provoke OspA-specific antibody responses with a strong Th1-bias (dominance of IgG2a response). In contrast, the adjuvant effects of Alum or parent MDP show a strong Th2-bias (dominance of IgG1 response).
- Published
- 2017
- Full Text
- View/download PDF
33. Multi-layered nanofibrous mucoadhesive films for buccal and sublingual administration of drug-delivery and vaccination nanoparticles - important step towards effective mucosal vaccines.
- Author
-
Mašek J, Lubasová D, Lukáč R, Turánek-Knotigová P, Kulich P, Plocková J, Mašková E, Procházka L, Koudelka Š, Sasithorn N, Gombos J, Bartheldyová E, Hubatka F, Raška M, Miller AD, and Turánek J
- Subjects
- Adhesives chemistry, Administration, Buccal, Administration, Sublingual, Animals, Liposomes chemistry, Lymph Nodes metabolism, Mice, Mouth Mucosa metabolism, Nanoparticles chemistry, Polyethylene Glycols chemistry, Polyglactin 910 chemistry, Swine, Vaccination methods, Drug Delivery Systems methods, Nanofibers chemistry, Pharmaceutical Preparations administration & dosage, Vaccines administration & dosage
- Abstract
Nanofibre-based mucoadhesive films were invented for oromucosal administration of nanocarriers used for delivery of drugs and vaccines. The mucoadhesive film consists of an electrospun nanofibrous reservoir layer, a mucoadhesive film layer and a protective backing layer. The mucoadhesive layer is responsible for tight adhesion of the whole system to the oral mucosa after application. The electrospun nanofibrous reservoir layer is intended to act as a reservoir for polymeric and lipid-based nanoparticles, liposomes, virosomes, virus-like particles, dendrimers and the like, plus macromolecular drugs, antigens and/or allergens. The extremely large surface area of nanofibrous reservoir layers allows high levels of nanoparticle loading. Nanoparticles can either be reversibly adsorbed to the surface of nanofibres or they can be deposited in the pores between the nanofibres. After mucosal application, nanofibrous reservoir layers are intended to promote prolonged release of nanoparticles into the submucosal tissue. Reversible adsorption of model nanoparticles as well as sufficient mucoadhesive properties were demonstrated. This novel system appears appropriate for the use in oral mucosa, especially for sublingual and buccal tissues. To prove this concept, trans-/intramucosal and lymph-node delivery of PLGA-PEG nanoparticles was demonstrated in a porcine model. This system can mainly be used for sublingual immunization and the development of "printed vaccine technology"., (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
34. [IgA nephropathy - research-generated questions].
- Author
-
Raška M, Zadražil J, Horynová MS, Kafková LR, Vráblíková A, Matoušovic K, Novak J, and Městecký J
- Subjects
- Glycosylation, Humans, Immunoglobulin A, Kidney, Glomerular Mesangium physiopathology, Glomerulonephritis, IGA etiology, Glomerulonephritis, IGA therapy, Kidney Failure, Chronic
- Abstract
IgA nephropathy (IgAN) is the most common type of glomerulonephritis. Its etiology involves an increased production of polymeric immunoglobulin A1 with an abnormal composition of some carbohydrate chains. The reaction of these abnormal forms of IgA1 with specific autoantibodies while circulating immune complexes arise and settle in the renal mesangium with subsequent inflammatory activation of mesangial cells which in up to 50% of cases results in end-stage kidney failure. Pathogenesis involves an interplay of genetic predisposition and environmental effects, mainly of microbial nature. Current therapy is not sufficiently effective and lacks the focus on the cause of the disease, therefore more efficient and specific ways of therapy are being sought to target the individual stages of the pathogenetic process of IgAN development. With the accumulation of knowledge, new questions arise, concerning detailed mechanisms of the pathological processes, as discussed in the text.Key words: autoimmunity - glycosylation of IgA hinge region - IgA nephropathy - immunoglobulin IgA - IgA1 hinge region.
- Published
- 2016
35. Liposomal nanocarriers for plasminogen activators.
- Author
-
Koudelka S, Mikulik R, Mašek J, Raška M, Turánek Knotigová P, Miller AD, and Turánek J
- Subjects
- Animals, Fibrinolysin therapeutic use, Fibrinolytic Agents therapeutic use, Humans, Liposomes ultrastructure, Metalloendopeptidases therapeutic use, Nanostructures chemistry, Nanostructures ultrastructure, Streptokinase therapeutic use, Thromboembolism drug therapy, Thrombolytic Therapy methods, Tissue Plasminogen Activator therapeutic use, Urokinase-Type Plasminogen Activator therapeutic use, Fibrinolysin administration & dosage, Fibrinolytic Agents administration & dosage, Liposomes chemistry, Metalloendopeptidases administration & dosage, Streptokinase administration & dosage, Tissue Plasminogen Activator administration & dosage, Urokinase-Type Plasminogen Activator administration & dosage
- Abstract
Several plasminogen activators (PAs) have been found effective in treating different thromboembolic diseases. However, administration of conventional thrombolytic therapy is limited by a low efficacy of present formulations of PAs. Conventional treatments using these therapeutic proteins are associated with several limitations including rapid inactivation and clearance, short half-life, bleeding complications or non-specific tissue targeting. Liposome-based formulations of PAs such as streptokinase, tissue-plasminogen activator and urokinase have been developed to improve the therapeutic efficacy of these proteins. Resulting liposomal formulations were found to preserve the original activity of PAs, promote their selective delivery and improve thrombus targeting. Therapeutic potential of these liposome-based PAs has been demonstrated successfully in various pre-clinical models in vivo. Reductions in unwanted side effects (e.g., hemorrhage or immunogenicity) as well as enhancements of efficacy and safety were achieved in comparison to currently existing treatment options based on conventional formulations of PAs. This review summarizes present achievements in: (i) preparation of liposome-based formulations of various PAs, (ii) development of PEGylated and targeted liposomal PAs, (iii) physico-chemical characterization of these developed systems, and (iv) testing of their thrombolytic efficacy. We also look to the future and the imminent arrival of theranostic liposomal formulations to move this field forward., (Copyright © 2016 Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
36. Molecular adjuvants based on nonpyrogenic lipophilic derivatives of norAbuMDP/GMDP formulated in nanoliposomes: stimulation of innate and adaptive immunity.
- Author
-
Knotigová PT, Zyka D, Mašek J, Kovalová A, Křupka M, Bartheldyová E, Kulich P, Koudelka Š, Lukáč R, Kauerová Z, Vacek A, Horynová MS, Kozubík A, Miller AD, Fekete L, Kratochvílová I, Ježek J, Ledvina M, Raška M, and Turánek J
- Subjects
- Acetylmuramyl-Alanyl-Isoglutamine administration & dosage, Acetylmuramyl-Alanyl-Isoglutamine chemistry, Acetylmuramyl-Alanyl-Isoglutamine pharmacology, Acetylmuramyl-Alanyl-Isoglutamine therapeutic use, Adjuvants, Immunologic administration & dosage, Adjuvants, Immunologic chemistry, Adjuvants, Immunologic therapeutic use, Animals, Antibodies, Fungal blood, Antigens, Fungal immunology, Female, HSP90 Heat-Shock Proteins immunology, Liposomes, Mice, Mice, Inbred ICR, Microscopy, Atomic Force, Microscopy, Electron, Scanning, Microscopy, Electron, Transmission, Molecular Structure, Nanoparticles, Rabbits, Radiation Injuries, Experimental immunology, Radiation Injuries, Experimental prevention & control, Recombinant Proteins immunology, Survival Analysis, Acetylmuramyl-Alanyl-Isoglutamine analogs & derivatives, Adaptive Immunity drug effects, Adjuvants, Immunologic pharmacology, Drug Carriers chemistry, Immunity, Innate drug effects
- Abstract
Purpose: The aim of this work was to demonstrate an immunostimulatory and adjuvant effect of new apyrogenic lipophilic derivatives of norAbuMDP and norAbuGMDP formulated in nanoliposomes., Methods: Nanoliposomes and metallochelating nanoliposomes were prepared by lipid film hydration and extrusion methods. The structure of the liposomal formulation was studied by electron microscopy, AF microscopy, and dynamic light scattering. Sublethal and lethal γ-irradiation mice models were used to demonstrate stimulation of innate immune system. Recombinant Hsp90 antigen (Candida albicans) bound onto metallochelating nanoliposomes was used for immunisation of mice to demonstrate adjuvant activities of tested compounds., Results: Safety and stimulation of innate and adaptive immunity were demonstrated on rabbits and mice. The liposomal formulation of norAbuMDP/GMDP was apyrogenic in rabbit test and lacking any side effect in vivo. Recovery of bone marrow after sublethal γ-irradiation as well as increased survival of mice after lethal irradiation was demonstrated. Enhancement of specific immune response was demonstrated for some derivatives incorporated in metallochelating nanoliposomes with recombinant Hsp90 protein antigen., Conclusions: Liposomal formulations of new lipophilic derivatives of norAbuMDP/GMDP proved themselves as promising adjuvants for recombinant vaccines as well as immunomodulators for stimulation of innate immunity and bone-marrow recovery after chemo/radio therapy of cancer.
- Published
- 2015
- Full Text
- View/download PDF
37. Oxidative damage of U937 human leukemic cells caused by hydroxyl radical results in singlet oxygen formation.
- Author
-
Rác M, Křupka M, Binder S, Sedlářová M, Matušková Z, Raška M, and Pospíšil P
- Subjects
- Cell Line, Tumor, Cell Survival drug effects, Chromatography, High Pressure Liquid, Comet Assay, Electron Spin Resonance Spectroscopy, Humans, Hydrogen Peroxide toxicity, Iron toxicity, Leukemia metabolism, Leukemia pathology, Lipid Peroxidation drug effects, Malondialdehyde analysis, Microscopy, Confocal, Protein Carbonylation drug effects, Hydroxyl Radical toxicity, Oxidative Stress drug effects, Singlet Oxygen metabolism
- Abstract
The exposure of human cells to oxidative stress leads to the oxidation of biomolecules such as lipids, proteins and nuclei acids. In this study, the oxidation of lipids, proteins and DNA was studied after the addition of hydrogen peroxide and Fenton reagent to cell suspension containing human leukemic monocyte lymphoma cell line U937. EPR spin-trapping data showed that the addition of hydrogen peroxide to the cell suspension formed hydroxyl radical via Fenton reaction mediated by endogenous metals. The malondialdehyde HPLC analysis showed no lipid peroxidation after the addition of hydrogen peroxide, whereas the Fenton reagent caused significant lipid peroxidation. The formation of protein carbonyls monitored by dot blot immunoassay and the DNA fragmentation measured by comet assay occurred after the addition of both hydrogen peroxide and Fenton reagent. Oxidative damage of biomolecules leads to the formation of singlet oxygen as conformed by EPR spin-trapping spectroscopy and the green fluorescence of singlet oxygen sensor green detected by confocal laser scanning microscopy. It is proposed here that singlet oxygen is formed by the decomposition of high-energy intermediates such as dioxetane or tetroxide formed by oxidative damage of biomolecules.
- Published
- 2015
- Full Text
- View/download PDF
38. [IgA Nephropathy. Facts, uncertainties, and potential causal therapy approaches].
- Author
-
Matoušovic K, Městecký J, Vondrák K, Dušek J, Chvátalová E, Háček J, Horynová M, Kašperová A, Rossmann P, Šterzl I, and Raška M
- Subjects
- Humans, Disease Management, Glomerulonephritis, IGA therapy
- Abstract
IgA nephropathy is currently the most frequently investigated glomerulonephritis. The disease is defined by the presence of dominant or co-dominant deposits of IgA1 in the glomerular mesangium. Circulating immune complexes are most likely the source of the deposited IgA1. However, it is also possible that the aggregates of structurally altered IgA1 or enhanced binding to IgA receptors expressed on mesangial cells lead to deposition. The cause of the formation of immune complexes responsible for IgA nephropathy lies in the incomplete O-linked oligosaccharide side chains, which, due to the deficiency of corresponding glycosyltransferases, lack terminal galactose residues leading to the exposure of N-acetylgalactosamine. Naturally occurring antibodies of the IgG or IgA1 isotype bind to this sugar antigen. In the clinical course, we differentiate between the early stage usually characterized by hematuria, and a variable late stage characterized either by a clinical remission, by persistence of hematuria, or by increasing proteinuria and blood pressure and decreasing renal function in one third of the patients. In the early stage, it is difficult to predict the prognosis of IgA nephropathy, either on the basis of clinical presentation and morphological findings, or according to the level of galactose-deficient IgA1 in the circulation. The reliable criteria of serious prognosis emerge only in the later stages of the disease and include proteinuria, hypertension, and histologically apparent tubular atrophy and interstitial sclerosis. The dominant trend in the treatment of IgA nephropathy is the emphasis on administration of ACE inhibitors/sartans, which are introduced into the treatment at the time of microalbuminuria. If proteinuria does not decrease below 1 g/24 h, treatment with prednisone is justifiable. New findings concerning the molecular/cellular mechanism involved in the pathogenesis of IgA nephropathy suggest the possible therapeutical interference with the generation of nephritogenic immune complexes by a selective blocking of the IgA1 molecules with altered glycan structures using monovalent reagents.
- Published
- 2015
39. Aberrant O-glycosylation and anti-glycan antibodies in an autoimmune disease IgA nephropathy and breast adenocarcinoma.
- Author
-
Stuchlová Horynová M, Raška M, Clausen H, and Novak J
- Subjects
- Amino Acid Sequence, Animals, Antibodies chemistry, Breast immunology, Carbohydrate Sequence, Female, Glycosylation, Humans, Immunoglobulin A chemistry, Molecular Sequence Data, Mucin-1 chemistry, Polysaccharides chemistry, Adenocarcinoma immunology, Antibodies immunology, Breast Neoplasms immunology, Glomerulonephritis, IGA immunology, Immunoglobulin A immunology, Mucin-1 immunology, Polysaccharides immunology
- Abstract
Glycosylation abnormalities have been observed in autoimmune diseases and cancer. Here, we compare mechanisms of aberrant O-glycosylation, i.e., formation of Tn and sialyl-Tn structures, on MUC1 in breast cancer, and on IgA1 in an autoimmune disease, IgA nephropathy. The pathways of aberrant O-glycosylation, although different for MUC1 and IgA1, include dysregulation in glycosyltransferase expression, stability, and/or intracellular localization. Moreover, these aberrant glycoproteins are recognized by antibodies, although with different consequences. In breast cancer, elevated levels of antibodies recognizing aberrant MUC1 are associated with better outcome, whereas in IgA nephropathy, the antibodies recognizing aberrant IgA1 are part of the pathogenetic process.
- Published
- 2013
- Full Text
- View/download PDF
40. Enhancement of immune response towards non-lipidized Borrelia burgdorferi recombinant OspC antigen by binding onto the surface of metallochelating nanoliposomes with entrapped lipophilic derivatives of norAbuMDP.
- Author
-
Křupka M, Mašek J, Bartheldyová E, Turánek Knötigová P, Plocková J, Korvasová Z, Škrabalová M, Koudelka Š, Kulich P, Zachová K, Czerneková L, Strouhal O, Horynová M, Šebela M, Miller AD, Ledvina M, Raška M, and Turánek J
- Subjects
- Acetylmuramyl-Alanyl-Isoglutamine toxicity, Animals, Calorimetry, Differential Scanning, Chelating Agents toxicity, Drug Carriers toxicity, Electrophoresis, Polyacrylamide Gel, Enzyme-Linked Immunosorbent Assay, Female, Light, Liposomes, Lyme Disease Vaccines administration & dosage, Mice, Mice, Inbred BALB C, Microscopy, Electron, Transmission, Nanoparticles toxicity, Scattering, Radiation, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Acetylmuramyl-Alanyl-Isoglutamine chemistry, Antibodies, Bacterial blood, Antigens, Bacterial immunology, Bacterial Outer Membrane Proteins immunology, Borrelia burgdorferi immunology, Chelating Agents chemistry, Drug Carriers chemistry, Lyme Disease Vaccines immunology, Nanoparticles chemistry
- Abstract
Lyme disease caused by spirochete Borrelia burgdorferi sensu lato, is a tick-born illness. If the infection is not eliminated by the host immune system and/or antibiotics, it may further disseminate and cause severe chronic complications. The immune response to Borrelia is mediated by phagocytic cells and by Borrelia-specific complement-activating antibodies associated with Th1 cell activation. A new experimental vaccine was constructed using non-lipidized form of recombinant B. burgdorferi s.s. OspC protein was anchored by metallochelating bond onto the surface of nanoliposomes containing novel nonpyrogenic lipophilized norAbuMDP analogues denoted MT05 and MT06. After i.d. immunization, the experimental vaccines surpassed Alum with respect to OspC-specific titers of IgG2a, IgG2b isotypes when MT06 was used and IgG3, IgM isotypes when MT05 was used. Both adjuvants exerted a high adjuvant effect comparable or better than MDP and proved themselves as nonpyrogenic., (Copyright © 2012 Elsevier B.V. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
41. Production of N-acetylgalactosaminyl-transferase 2 (GalNAc-T2) fused with secretory signal Igκ in insect cells.
- Author
-
Horynová M, Takahashi K, Hall S, Renfrow MB, Novak J, and Raška M
- Subjects
- Amino Acid Sequence, Animals, Baculoviridae genetics, Baculoviridae metabolism, Cloning, Molecular, Culture Media metabolism, Enzyme Activation, Genetic Vectors genetics, Genetic Vectors metabolism, HEK293 Cells, Humans, Immunoglobulin A genetics, Immunoglobulin A metabolism, Immunoglobulin kappa-Chains genetics, Insecta genetics, Insecta metabolism, Mice, Molecular Sequence Data, N-Acetylgalactosaminyltransferases genetics, N-Acetylgalactosaminyltransferases isolation & purification, Plasmids genetics, Plasmids metabolism, Protein Sorting Signals, Protein Stability, Recombinant Fusion Proteins genetics, Recombinant Fusion Proteins isolation & purification, Solubility, Tandem Mass Spectrometry, Transfection, Polypeptide N-acetylgalactosaminyltransferase, Immunoglobulin kappa-Chains chemistry, N-Acetylgalactosaminyltransferases biosynthesis, Recombinant Fusion Proteins biosynthesis
- Abstract
The human UDP-N-acetyl-α-d-galactosamine:polypeptide N-acetylgalactosaminyl-transferase 2 (GalNAc-T2) is one of the key enzymes that initiate synthesis of hinge-region O-linked glycans of human immunoglobulin A1 (IgA1). We designed secreted soluble form of human GalNAc-T2 as a fusion protein containing mouse immunoglobulin light chain kappa secretory signal and expressed it using baculovirus and mammalian expression vectors. The recombinant protein was secreted by insect cells Sf9 and human HEK 293T cells in the culture medium. The protein was purified from the media using affinity Ni-NTA chromatography followed by stabilization of purified protein in 50mM Tris-HCl buffer at pH 7.4. Although the purity of recombinant GalNAc-T2 was comparable in both expression systems, the yield was higher in Sf9 insect expression system (2.5mg of GalNAc-T2 protein per 1L culture medium). The purified soluble recombinant GalNAc-T2 had an estimated molecular mass of 65.8kDa and its amino-acid sequence was confirmed by mass-spectrometric analysis. The enzymatic activity of Sf9-produced recombinant GalNAc-T2 was determined by the quantification of enzyme-mediated attachment of GalNAc to synthetic IgA1 hinge-region peptide as the acceptor and UDP-GalNAc as the donor. In conclusion, murine immunoglobulin kappa secretory signal was used for production of secreted enzymatically active GalNAc-T2 in insect baculovirus expression system., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
42. Metallochelating liposomes with associated lipophilised norAbuMDP as biocompatible platform for construction of vaccines with recombinant His-tagged antigens: preparation, structural study and immune response towards rHsp90.
- Author
-
Mašek J, Bartheldyová E, Turánek-Knotigová P, Skrabalová M, Korvasová Z, Plocková J, Koudelka S, Skodová P, Kulich P, Křupka M, Zachová K, Czerneková L, Horynová M, Kratochvílová I, Miller AD, Zýka D, Michálek J, Vrbková J, Sebela M, Ledvina M, Raška M, and Turánek J
- Subjects
- Animals, Antigens, Fungal metabolism, Candida immunology, Cells, Cultured, Chelating Agents chemistry, Coated Materials, Biocompatible metabolism, Dendritic Cells immunology, Dendritic Cells metabolism, Female, HSP90 Heat-Shock Proteins metabolism, Humans, Liposomes, Mice, Mice, Inbred BALB C, Nickel immunology, Vaccines, Synthetic immunology, Vaccines, Synthetic metabolism, Antigens, Fungal immunology, Chelating Agents metabolism, HSP90 Heat-Shock Proteins immunology, Immunity, Cellular, Nickel metabolism
- Abstract
Hsp90-CA is present in cell wall of Candida pseudohyphae or hyphae-typical pathogenic morphotype for both systemic and mucosal Candida infections. Heat shock protein from Candida albicans (hsp90-CA) is an important target for protective antibodies during disseminated candidiasis of experimental mice and human. His-tagged protein rHsp90 was prepared and used as the antigen for preparation of experimental recombinant liposomal vaccine. Nickel-chelating liposomes (the size around 100nm, PDI≤0.1) were prepared from the mixture of egg phosphatidyl choline and nickel-chelating lipid DOGS-NTA-Ni (molar ratio 95:5%) by hydration of lipid film and extrusion methods. New non-pyrogenic hydrophobised derivative of MDP (C18-O-6-norAbuMDP) was incorporated into liposomes as adjuvans. rHsp90 was attached onto the surface of metallochelating liposomes by metallochelating bond and the structure of these proteoliposomes was studied by dynamic light scattering, AF microscopy, TEM and GPC. The liposomes with surface-exposed C18-O-6-norAbuMDP were well recognised and phagocyted by human dendritic cells in vitro. In vivo the immune response towards this experimental vaccine applied in mice (i.d.) demonstrated both TH1 and TH2 response comparable to FCA, but without any side effects. Metallochelating liposomes with lipophilic derivatives of muramyl dipeptide represent a new biocompatible platform for construction of experimental recombinant vaccines and drug-targeting systems., (Copyright © 2010 Elsevier B.V. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
43. Immobilization of histidine-tagged proteins on monodisperse metallochelation liposomes: Preparation and study of their structure.
- Author
-
Mašek J, Bartheldyová E, Korvasová Z, Skrabalová M, Koudelka S, Kulich P, Kratochvílová I, Miller AD, Ledvina M, Raška M, and Turánek J
- Subjects
- Green Fluorescent Proteins chemistry, Green Fluorescent Proteins genetics, Green Fluorescent Proteins metabolism, HIV Envelope Protein gp120 chemistry, HIV Envelope Protein gp120 genetics, HIV Envelope Protein gp120 metabolism, HIV-1 metabolism, Histidine chemistry, Histidine genetics, Histidine metabolism, Humans, Immobilized Proteins genetics, Immobilized Proteins metabolism, Micelles, Microscopy, Atomic Force, Microscopy, Electron, Transmission, Oligopeptides chemistry, Oligopeptides genetics, Oligopeptides metabolism, Proteolipids chemistry, Ultrafiltration methods, Chelating Agents chemistry, Immobilized Proteins chemistry, Liposomes chemistry, Nickel chemistry
- Abstract
Liposomes represent a biocompatible platform for the construction of self-assembling proteoliposomes using nickel or zinc metallochelation. Potential applications of such structures consist in the development of new biocompatible vaccination nanoparticles and drug delivery nanoparticle systems. Here, we describe the design and construction of a flow-through ultrafiltration cell suitable for the preparation of monodisperse liposomes enabled for metallochelation and, hence, the formation of proteoliposomes. The linkage of the cell with a fast protein liquid chromatography system facilitates automation of the procedure, which fits the criteria for upscaling. Proof-of-concept experiments are performed using a mixture of egg phosphatidyl choline and nickel-chelating lipid DOGS-NTA-Ni (1,2-dioleoyl-sn-glycero-3-{[N(5-amino-1-carboxypentyl)iminodiacetic acid]succinyl}(nickel salt)) to formulate proteoliposomes with proteins attached by metallochelation, including histidine (His)-tagged recombinant green fluorescent protein and rgp120 (derived from HIV-1 Env). These model proteoliposomes are characterized by gel permeation chromatography and by dynamic light scattering. Transmission electron microscopy and immunogold staining are used to characterize surface-bound proteins, revealing the tendency of rgp120 to form microdomains on liposome surfaces. These microdomains possess a two-dimensional crystal-like structure that is seen more precisely by atomic force microscopy., (Copyright © 2010 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.